Tag Archives: Myriad lawsuit

Supreme Court Remands In Myriad Appeal

Posted on March 26, 2012 by Warren Woessner

Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biotechnology, biotechnology news, DNA, Federal Circuit, intellectual property, ip, Myriad, Myriad lawsuit, patent attorney, Patent Law, patents, Supreme Court, Warren Woessner | 1 Comment

AMP Petitions for Cert. and A Look Back

Posted on December 16, 2011 by Warren Woessner

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged ACLU, AMP, Association of Molecular Pathology, biotechnology, biotechnology law, biotechnology news, BRCA DNA, Chakrabarty, diagnostic methods, Federal Circuit, Myriad, Myriad lawsuit, patent attorney, Patent Law, patents, SLW, Supreme Court, Warren Woessner | 1 Comment

Myriad Petition For Rehearing Denied

Posted on September 14, 2011 by Warren Woessner

On September 13, 2011, the Fed. Cir. panel in AMP v. Myriad denied AMP’s (read ACLU’s) petition for rehearing by the panel. (A copy of the petition can be found at the end of this post.) In challenging the holding … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged AMP, biotechnology, biotechnology law, Federal Circuit, intellectual property, ip, Myriad, Myriad lawsuit, patent attorney, patent claims, Patent Law, patents, Warren Woessner | Leave a comment

Wegner Paper Probes Myriad Decisions Flaws

Posted on August 2, 2011 by Warren Woessner

Prof. Hal Wegner goes for the jugular with his analysis of some of the flaws in the legal reasoning behind the holding in the recent AMC v. Myriad decision. [See my post of July 31st 2011 on the decision]. (Prof. … Continue reading →